vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
14.83
-0.82 (-5.24%)
Nov 21, 2024, 4:00 PM EST - Market closed
vTv Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 45 | 23 | 54 | 67 | 98 | 70 | |
| Market Cap Growth | -15.27% | -56.62% | -18.92% | -32.00% | 40.81% | 29.01% | |
| Enterprise Value | -1 | 27 | 64 | 93 | 144 | 113 | |
| Last Close Price | 15.46 | 11.50 | 26.51 | 39.80 | 74.40 | 68.00 | |
| PS Ratio | 71.81 | - | 26.76 | 16.63 | 15.27 | 25.17 | |
| PB Ratio | 2.69 | -1.26 | 9.25 | 4.38 | 25.82 | -7.87 | |
| EV/Sales Ratio | - | - | 31.69 | 23.20 | 22.52 | 40.90 | |
| Debt / Equity Ratio | 0.01 | -0.03 | 0.12 | 0.06 | 0.24 | -0.80 | |
| Asset Turnover | 0.03 | - | 0.07 | 0.20 | 0.53 | 0.31 | |
| Quick Ratio | 6.52 | 0.91 | 1.60 | 1.61 | 0.98 | 0.15 | |
| Current Ratio | 6.69 | 1.00 | 3.52 | 1.84 | 1.13 | 0.21 | |
| Return on Equity (ROE) | -1335.04% | - | -238.10% | -186.49% | - | - | |
| Return on Assets (ROA) | -51.63% | -72.03% | -47.99% | -62.28% | -61.59% | -146.51% | |
| Return on Capital (ROIC) | -671.60% | - | -124.07% | -120.21% | -496.98% | - | |
| Earnings Yield | -39.46% | -86.44% | -35.48% | -19.50% | -8.68% | -18.75% | |
| FCF Yield | -81.45% | -29.71% | -28.99% | -18.38% | -33.19% | |
| Buyback Yield / Dilution | -15.34% | -8.60% | -22.58% | -32.90% | -55.61% | -143.32% | |
| Total Shareholder Return | -15.34% | -8.60% | -22.58% | -32.90% | -55.61% | -143.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.